Tag Archives: Dopamine

Safinamide in Parkinson’s Disease

  Background The rather specific dopaminergic deficit in Parkinson’s disease (PD) has meant that dopaminergic replacement medications have proven to be an effective mainstay of treatment of the condition. However, later on in the course of the disease, such treatment … Continue reading

Posted in Parkinson's Disease | Tagged , , , | Leave a comment

Primer on Parkinson’s Disease for General Readers

Pathology Parkinson’s Disease (PD) is a relatively common condition affecting around 1% of all individuals aged over 60, and increasing towards 5% of those over 80. It is characterised by neurodegeneration, a “wearing out” of certain groups of nerve cells … Continue reading

Posted in Parkinson's Disease, Primer Posts for General Readers | Tagged , , | 2 Comments